These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Penicillin resistance in pneumococcal pneumonia. Antibiotics with low resistance potential are effective and pose less risk. Cunha BA Postgrad Med; 2003 Jan; 113(1):42-4, 47-8, 52-4. PubMed ID: 12545592 [TBL] [Abstract][Full Text] [Related]
9. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes? Rothermel CD Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368 [TBL] [Abstract][Full Text] [Related]
10. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438 [TBL] [Abstract][Full Text] [Related]
11. [Resistance to penicillin and erythromycin of Streptococcus pneumoniae and Streptococcus pyogenes isolated from community-acquired respiratory infections in Spain between 1986-1999 and its relationship with the use of beta-lactams and macrolides]. Granizo Martínez JJ Rev Esp Quimioter; 2005 Mar; 18(1):83-5. PubMed ID: 15915241 [No Abstract] [Full Text] [Related]
12. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451 [TBL] [Abstract][Full Text] [Related]
14. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae. Yayan J Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917 [TBL] [Abstract][Full Text] [Related]
15. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae. Lee WK; Young BW J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621 [No Abstract] [Full Text] [Related]
16. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started. Mufson MA; Chan G; Stanek RJ Am J Med Sci; 2007 Mar; 333(3):161-7. PubMed ID: 17496734 [TBL] [Abstract][Full Text] [Related]
18. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia]. Sánchez C; Armengol R; Mir I; Lite J; Garau J Enferm Infecc Microbiol Clin; 1992; 10(6):334-9. PubMed ID: 1391015 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of invasive infections in children caused by highly penicillin-resistant Streptococcus pneumoniae compared with infections caused by penicillin-susceptible strains. Gómez-Barreto D; Calderón-Jaimes E; Rodríguez RS; de los Monteros LE Arch Med Res; 2000; 31(6):592-8. PubMed ID: 11257327 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand. Srifuengfung S; Tribuddharat C; Champreeda P; Daniels J; Chokephaibulkit K; Wongwan N; Polwichai P Southeast Asian J Trop Med Public Health; 2008 May; 39(3):461-6. PubMed ID: 18564685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]